Scotland’s Hepatitis C Action Plan, a patient approach?

Slides:



Advertisements
Similar presentations
Establishing a Managed Care Network for Hepatitis C
Advertisements

Hepatitis C Education, Training & Awareness-raising Network Phase II Actions NHS Greater Glasgow and Clyde Hepatitis C Managed Care Network Event 11 June.
Social Prescribing in the Community Bromley by bow centre presentation
© INTERNATIONAL GLAUCOMA ASSOCIATION (274681) 2009 Scottish Vision Strategy John Hughes IGA Development Manager - Scotland Stirling Management Centre 26.
Tobacco control and the new structures for public health Professor Kevin Fenton Director of Health & Wellbeing Twitter:
Managed Knowledge Networks for Cancer, Coronary Heart Disease and Mental Health in the West of Scotland Annette Thain MKN Project Manager
The current management of vasomotor symptoms in breast cancer patients in the UK: Clinician versus Patient perspective. Mei-Lin Ah-See 1,Charlotte Coles.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Alcohol-Related Harm and Unmet Need Amongst Older Drinkers S Wadd, R Driver, D Forrester.
STROKE AUDIT Why? What? Who? Sandi haines Stroke Coordinator NHS Borders.
Alcohol Brief Interventions in Scotland: Research & Evaluation Andrew McAuley Public Health Adviser (Substance Misuse / Alcohol) NHS Health Scotland INEBRIA,
14078 – Final Voting. 10:00 – 10:30 session – Kathy Headdon.
Needs Assessment of Hepatitis C Testing, Treatment and Support Services: Survey of Laboratories in Scotland Undertaking Hepatitis C Testing.
National Hepatitis C Database Dr Lelia Thornton Health Protection Surveillance Centre December 2012.
Modelled impact of antiviral therapy on the future burden of HCV disease in Scotland Testing/Treatment/Care Working Group, 11 th Sept 2007.
Treating Hepatitis C in Methadone Patients: With Planning, it Works! Patricia Perkins, MS, MPH Independent Healthcare Consultant Community Advisory Board.
Setting Priorities Delivering Best Value Managing Scarcity: Experience from Tayside Danny Ruta.
The Malnutrition Task Force : Prevention and early intervention of malnutrition in later life Margit Physant Project Manager.
Tom Wainwright, NHS Elect Associate Wareham, 7 th August 2014 An Appetite For Change in Purbeck The National Picture and Background.
Sue Hawkins Care Catering Services Manager Malnutrition Task Force Update Prevention and early intervention of malnutrition in later life.
Management of Chronic HCV Infection by PMDs Rod Rahimi Osler Journal Club
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Testing, Treatment, Care and Support Draft Actions for Phase II.
Rhona Hunter Team Manager Jayne Reed Senior Community Mental Health Nurse.
NHS Norfolk NHS Great Yarmouth and Waveney “An Update: – where are we with developments for people with dementia in Norfolk?” Dementia Strategy for Norfolk.
WLCCG Cancer QP Dr Pawan Randev WLCCG Cancer Lead GP 20 th June 2013.
Hepatitis C Testing in the Muslim Community Hasnain Jafferbhoy Grampian Hepatitis Stakeholder Conference 16 th June 2011.
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PWID) PREVIOUSLY SUCCESFULY TREATED G. Ntetskas, V. Papastergiou, L. Skorda, A. Katsili, E. Anastasiou,
How Big is the Alcohol Problem Locally? Jess Mookherjee Consultant in Public Health Kent.
Drug Use and Hepatitis C Are we mindful of the gaps? Dave Liddell, SDF.
Improving Nutrition on the Wards Nutrition and Patient Safety Implementing the 10 Key Characteristics of Good Nutritional Care.
Marlene Harkis Development manager Scottish Centre Telehealth and Telecare/NHS24.
Patient Information Forum (PiF) Overview.
Needs Assessment of Hepatitis C Testing, Treatment and Support Services: Survey of General Practitioners in Primary Care.
1 Kennedy Roberts Senior Medical Officer and Clinical Lead North Cluster Glasgow Addiction Services Community Addiction Teams What are the challenges for.
Physical Activity in North Wales Julie A Jones Macmillan Services Effectiveness Lead June 2015.
Testing, Treatment, Care and Support Revised Actions for Phase II.
Dr Mary Backhouse Chief Clinical Officer Our ‘Big Questions’
CCG commissioning and mental health Mark Burdon, Commissioning Manager (Mental Health), South Tees CCG CCG commissioning and mental health Mark Burdon,
The Implementation Plan for Rare Diseases in Scotland abcdefghijklmnopqrstuabcdefghijklmnopqrstu.
An Introduction to Genetic Alliance UK’s Work in Scotland Natalie Frankish – Development Officer for Scotland Event:Action Duchenne Scottish Conference.
How aspirations can be built and levels of performance can be assured: Learning from the Scottish Action Plan Professor Sharon Hutchinson LJWG LDAPF Conference.
Hepatitis C Needs Assessment: Contributions from the National HCV Diagnosis and Local Clinical Databases.
QUALITY INDICATORS FOR HEPATITIS C Michele Hilton Boon Ray Fox, Clare Echlin, Scott Horton, Hepatitis C Project Group.
England Council Acts locally to improve services Shares best practice with branches Presents the views of people with and affected by MS in England to.
Hep C clinic Jessie Anderson, Cathy Scott, Kim Macbeth, Dave Findlay and John Budd Edinburgh Access Practice.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
Alcohol Drugs and Hepatitis C, Brewing up a perfect storm COSLA Haymarket, Edinburgh 24 June 2015 Epidemiological overview Professor David Goldberg, Health.
Developing a national governance framework for health promotion in Scottish hospitals Lorna Smith Senior Health Improvement Programme Officer NHS Health.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Hepatitis C, Alcohol and ORT What are the experiences of people using services? A presentation by Lorraine, Paul and Paul.
Services and C Leon Wylie Lead Officer Hepatitis Scotland.
Evelina London Child Health Programme Integrating services Claire Lemer 29 th April 2014.
What is the contribution of alcohol to liver disease in the hepatitis C infected population. The epidemiological evidence Hamish Innes Research Fellow.
NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.
The Role of Psychology Within Addiction Services Dr Mette Kreis, Clinical Psychologist Prison Addiction Clinical Psychology Service, NHS Forth Valley Dr.
Health and Homelessness: Shared Solutions 17 th March 2009 Edinburgh Richard Norris Director, Scottish Health Council.
Hepatitis C and Sexual & Reproductive Health Graham Mackintosh, Training & Capacity Officer Lesley Bon, Patient Involvement Officer.
Operational Delivery Networks for the Treatment of Hepatitis C.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
National Hepatitis C Database
INCLUSION: Public Health interventions in substance misuse Faculty of public health conference, 2017 Welcome.
Cascade of care for persons newly diagnosed
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Hepatitis B and C management pathways in prison:
Blood borne viral hepatitis action in Wales
Hepatitis C Testing, Treatment, Care and Support
Hepatitis C case-finding – An opportunity for community pharmacy
Presentation transcript:

Scotland’s Hepatitis C Action Plan, a patient approach?

Except £12000 Funding

Scotland Population: 5.2 million (~60% in the 4 main NHS Boards) HCV ever infected population: ~ 50,000 (~ 90% have injected drugs) Current IDU population: ~ 24,000 (~70% in the 4 main NHS Boards) Prevalence of HCV among current IDUs estimated at 50% Aberdeen Dundee Edinburgh Glasgow

based on an extensive evidence base and consultation process high level embraces all service needs adopts a multidisciplinary approach (MCNs!) covered all geographical areas and settings performance managed supported by serious investment addresses inequalities

New clients presenting at drug services: Scotland ,325 sought help with drug use 41% using illicit drugs at age 15 80% using illicit drugs by age 19 55% have injected drugs 33% of injectors initiated by age 20 38% shared needles/syr by 20 58% shared other equipment by age 20

A little about me Kenny, 56 years old I have a wife and a daughter I like to be active, walking and sports

My Drug Use A bit different than what you would expect I used mostly at weekends Not everyday, or for long periods

I was a Functioning Drug User G.P. Every 3 years for BBV Test 2007 – Tests came back negative 2010 – Letter arrive

I have Hepatitis C Referral Hospital C Plus, had a key worker

The hardest thing..... Informing my family We are very close cats They’ve stood shoulder to shoulder with me

But started to get Educated Attended my support group Learning about BBVs I kept a diary

Diary of Treatment Kept my appointment dates D.N.A Built professional friendships with treatment nurses

Started Treatment June 2011, Genotype 1, 48 Weeks Ribavirin and Interferon Blood taken every 2 weeks Morning Appointments, 4 buses for round trip

My Experience of Treatment Physical and Mental effects Fatigue Flu like symptoms Leg and Feet ulcers Headaches Nightmares

But in December.... I had lost the battle No SVR But I hope to win the war This was a time to reflect

The Power of Knowledge Being Informed about your condition Informing others of your experience Hearing of other people’s experiences

Taking Ownership I Restructured my Life And I took responsibility for my actions And I started to get involved

Open Doors Recovery Summit Hepatitis Scotland Peer Researcher Member of the National Patient Forum Joined Hepatitis Scotland’s Advisory Board 3 rd National Recovery Conference Scottish Drugs Forum Conferences World Hepatitis Day Community Action Research Project

2 days ago Because of the National Patient Forum - Scotland held a Conference for People who have been diagnosed with Hepatitis C Key experts in the field aiming information directly to those affected Gathered information from those who attended as well

Finally Humble to be back in Dublin Thank you for inviting me

Summary

A note of caution: What is the contribution of lifestyle factors Spontaneous resolvers exhibit high rates of adverse liver-related outcomes (18-27 times that of the Scottish general population); Innes et al; Hepatology. 2011;54(5) Among Scottish HCV patients, 1/3 of liver cirrhosis cases are attributable to heavy alcohol consumption; Innes et al; Hepatology. 2013;57(2) Eliminating HCV infection and eliminating liver disease are not synonymous. Cannot ignore the importance of addressing lifestyle factors in an IFN-free age.

Hepatitis Scotland 1 st Floor, 91 Mitchell Street, Glasgow, G1 3LN phone: facebook: Hepatitis-Scotland

NGO Involvement Pre 2003 UK Hepatitis Resource Centre (UK HCRC) (forerunner of Hepatitis Scotland) National Hepatitis C Stakeholder Conference in Edinburgh opened by First Minister Conference reception with First Minister Malcolm Chisholm held in Edinburgh Castle 2003 First National Hepatitis C Awareness Day in Scotland (UK HCRC led) National Hepatitis C Awareness Day in England held (Mainliners UK HCRC in partnership with British Liver Trust, Hepatitis C Trust, Eddystone Trust, Plus VE, UK Haemophilia Society) 2004 First UK Hepatitis C Awareness Day held (Mainliners UK HCRC in partnership with British Liver Trust, Hepatitis C Trust, Eddystone Trust, Plus VE, UK Haemophilia Society and local orgs across Scotland and rest of UK) Hepatitis C Parliamentary Event held as part of above (UK HCRC led) Hepatitis C Parliamentary Event in the Scottish Parliament, crucially all parties contributed to the event calling for an Action Plan. Raft of Parliamentary Questions (PQs) submitted to the Scottish Parliament by UK HCRC to continue to raise profile/awareness amongst MSPs Scottish Hepatitis C Parliamentary Group established by UK HCRC

2005 First draft Hepatitis C Action Plan published. Broad third sector input to consultation Following publication, governance and national groups were established to coordinate and support the implementation of the Action Plan Phase I. Each group included third sector representation primarily through Scottish Drugs Forum, UKHCRC Scottish Drugs Forum, Mainliners UKHCRC, Hepatitis C Trust and patient group representatives were members of the Hepatitis C Action Plan Phase I Coordinating Group established to monitor implementation of the Plan and draft actions subsequently for Phase II. Range of third sector representatives attended national consultation event to vote on actions for Phase II Action Plan. Hepatitis C Trust established in Scotland by then and became part of Advisory Committee for the Hepatitis C Action Plan which encompassed representation from across the UK. Hepatitis C Awareness Days and Parliamentary Events held in the Scottish Parliament each year – national supply of resources (posters, leaflets etc) to NHS Boards and services across Scotland via UKHCRC 2008 Phase II Action plan published Scottish Drugs Forum, UKHCRC, Hep C Trust and patient group representatives were members of the Hepatitis C Action Plan Phase Coordinating Group established to monitor implementation of the Plan and other national networks Hepatitis C Third sector Network established

Hepatitis C in Scotland: Milestones 1989Discovery of HCV 1991Antibody Test 1992Interferon Therapy 1996 HCV Diagnosis Database Prevalence Surveys 1998Interferon + Ribavirin Therapy 1999Needs Assessment 2001Pegylated Interferon +Ribavirin Therapy 2003UK Hepatitis C Resource Centre Clinical Database established 2004Consensus Conference (RCP, Edin) 2004Parliamentary Working Group on Hepatitis C Action Plan Phase I 2007SIGN Guidelines 2008Public Enquiry: Hepatitis C infection through NHS Treatment Action Plan Phase II